Mostrando 5,141 - 5,160 Resultados de 5,191 Para Buscar '"RBD"', tiempo de consulta: 0.17s Limitar resultados
  1. 5141
    “…Mutations affecting spike proteins are mostly found in RBD regions for Omicron, whereas most of the Delta variant mutations drawn to focus on amino acid regions ranging from 911 to 924 in the context of epitope prediction (B cell & T cell) and mutational stability impact analysis protruding that Omicron is more transmissible. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Variant-specific deleterious mutations in the SARS-CoV-2 genome reveal immune responses and potentials for prophylactic vaccine development
  2. 5142
    “…B-cell responses are being profiled by measuring anti-Spike serum IgG, RBD-ACE2 blocking activity, and spike-specific memory B cells. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Time Since Last Anti-CD20 Treatment Is a Major Determinant of Sars-Cov-2 Vaccine Response in a Large Cohort of Patients with B-Cell Lymphoma
  3. 5143
    “…BNT162b2 vaccination induced a detectable IgG anti-SARS-CoV-2 RBD response in saliva at both 2 and 6 months after vaccination, being more prominent in previously infected than infection-naive individuals. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Short-Lived Antibody-Mediated Saliva Immunity against SARS-CoV-2 after Vaccination
  4. 5144
    “…These data suggest that extensively mutating ACE2 residues near the receptor binding domain (RBD)-binding interface should be avoided or performed with extra caution. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Broadly Effective ACE2 Decoy Proteins Protect Mice from Lethal SARS-CoV-2 Infection
  5. 5145
    “…We estimated the association between a known SARS-CoV-2 serostatus (reported positive PCR test or vaccination) and self-reported PPM behavior (hand hygiene, physical distancing, wearing face mask), just as the association of PPM compliance with seropositivity against nucleocapsid (NC), receptor-binding domain (RBD), and spike protein (S) antigens. We identified relevant variables and deduced adjustment sets with directed acyclic graphs (DAG), and applied mixed logistic regression. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Association of known SARS-CoV-2 serostatus and adherence to personal protection measures and the impact of personal protective measures on seropositivity in a population-based cross-sectional study (MuSPAD) in Germany
  6. 5146
    “…Total SARS-CoV-2 spike (S) and receptor binding domain (RBD)-specific IgG antibodies, as well as endemic coronavirus (eCoV) antibodies, were measured using a multiplex microsphere immunoassay. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1720. Immunogenicity of COVID-19 Vaccines in Youth with Inflammatory Bowel Disease
  7. 5147
    “…In this study, we evaluated antibody responses and antigen-specific memory B cell responses over time in 33 SARS-CoV2 naïve and 11 SARS-CoV2 recovered subjects. mRNA vaccination induced significant antibody and memory B cell responses against full-length SARS-CoV2 spike protein and the spike receptor binding domain (RBD). SARS-CoV2 naïve individuals benefitted from both doses of mRNA vaccine with additional increases in antibodies and memory B cells following booster immunization. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Longitudinal Analysis Reveals Distinct Antibody and Memory B Cell Responses in SARS-CoV2 Naïve and Recovered Individuals Following mRNA Vaccination
  8. 5148
    por Goubet, Anne-Gaëlle, Dubuisson, Agathe, Geraud, Arthur, Danlos, François-Xavier, Terrisse, Safae, Silva, Carolina Alves Costa, Drubay, Damien, Touri, Lea, Picard, Marion, Mazzenga, Marine, Silvin, Aymeric, Dunsmore, Garett, Haddad, Yacine, Pizzato, Eugenie, Ly, Pierre, Flament, Caroline, Melenotte, Cléa, Solary, Eric, Fontenay, Michaela, Garcia, Gabriel, Balleyguier, Corinne, Lassau, Nathalie, Maeurer, Markus, Grajeda-Iglesias, Claudia, Nirmalathasan, Nitharsshini, Aprahamian, Fanny, Durand, Sylvère, Kepp, Oliver, Ferrere, Gladys, Thelemaque, Cassandra, Lahmar, Imran, Fahrner, Jean-Eudes, Meziani, Lydia, Ahmed-Belkacem, Abdelhakim, Saïdani, Nadia, La Scola, Bernard, Raoult, Didier, Gentile, Stéphanie, Cortaredona, Sébastien, Ippolito, Giuseppe, Lelouvier, Benjamin, Roulet, Alain, Andre, Fabrice, Barlesi, Fabrice, Soria, Jean-Charles, Pradon, Caroline, Gallois, Emmanuelle, Pommeret, Fanny, Colomba, Emeline, Ginhoux, Florent, Kazandjian, Suzanne, Elkrief, Arielle, Routy, Bertrand, Miyara, Makoto, Gorochov, Guy, Deutsch, Eric, Albiges, Laurence, Stoclin, Annabelle, Gachot, Bertrand, Florin, Anne, Merad, Mansouria, Scotte, Florian, Assaad, Souad, Kroemer, Guido, Blay, Jean-Yves, Marabelle, Aurélien, Griscelli, Frank, Zitvogel, Laurence, Derosa, Lisa
    Publicado 2021
    “…When comparing nasopharyngeal swabs from cancer and noncancer patients for RT-qPCR cycle thresholds measuring acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in 1063 patients (58% with cancer), we found that malignant disease favors the magnitude and duration of viral RNA shedding concomitant with prolonged serum elevations of type 1 IFN that anticorrelated with anti-RBD IgG antibodies. Cancer patients with a prolonged SARS-CoV-2 RNA detection exhibited the typical immunopathology of severe COVID-19 at the early phase of infection including circulation of immature neutrophils, depletion of nonconventional monocytes, and a general lymphopenia that, however, was accompanied by a rise in plasmablasts, activated follicular T-helper cells, and non-naive Granzyme B(+)FasL(+), Eomes(high)TCF-1(high), PD-1(+)CD8(+) Tc1 cells. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosis
  9. 5149
    “…However, the overall efficacies were assessed with sera that seroconverted against either nucleocapsid (NCP) or receptor-binding domain (RBD). RESULTS: In-house ELISA selected a total of 81 true seropositive and 100 seronegative samples. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    AuNP Coupled Rapid Flow-Through Dot-Blot Immuno-Assay for Enhanced Detection of SARS-CoV-2 Specific Nucleocapsid and Receptor Binding Domain IgG
  10. 5150
    “…There were five treatments laid in a randomized block design (RBD) with three replications; T(1) [Farmer practice on the flatbed with RDF @ N(120):P(60):K(60) + FYM @6.0 t ha(−1) without mulch], T(2) [T(1) + Polythene mulch (50 microns)], T(3) [Tomato plants grown on the raised bed with polythene mulch + FYM @ 8.0 t ha(−1) + Single shoot trellis system + Side shoot pruning + Liquid Fertilizer (LF(1)—N(19):P(19):K(19)) @ 2.0 g l(–1) for vegetative growth + Liquid Fertilizer (LF(2)—N(0): P(52): K(34)) @ 1.5 g l(–1) for improving fruit quality], T(4) [Tomato plants grown on the raised bed with polythene mulch + FYM @ 8.0 t ha(−1) + Single shoot trellis system + Side shoot pruning + LF(1) @ 4.0 g l(–1) + LF(2) @ 3.0 g l(–1)], and T(5) [Tomato plants grown on the raised bed with polythene mulch + FYM @ 10.0 t ha(−1) + Single shoot trellis system + Side shoot pruning + LF(1) @ 6.0 g l(–1) + LF(2) @ 4.5 g l(–1)]. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Modified plant architecture integrated with liquid fertilizers improves fruit productivity and quality of tomato in North West Himalaya, India
  11. 5151
    “…We then collected the serological status at day 30, of the first 129 patients that completed vaccination. 97 were affected by MM, 19 by SMM, 3 by MGRS, 10 by AL amyloidosis. 118 developed regular antibodies confirmed by the presence of the receptor binding domain of the spike protein (RBD) antibodies, while 7 presented nucleocapsid protein (N) antibodies, suggesting a previous contact with the virus in the absence of any clinical manifestation. 11 patients failed to develop any immunization, all had received immunosuppressive therapies (renal transplantation in 1, long-term corticosteroid in 1, cyclophosphamide in 7, anti-CD20 monoclonal antibodies in 2) or multiple previous lines of therapies. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    P-147: COVID-19, impact of vaccination in myeloma patients
  12. 5152
    “…We did not detect an increased frequency of any receptor-binding domain (RBD)/N-terminal domain (NTD) polymorphism between groups (P > 0.05). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Postvaccination SARS-COV-2 among Health Care Workers in New Jersey: A Genomic Epidemiological Study
  13. 5153
    “…At the end of follow-up we measured humoral response to SARS-CoV2 by assessing total antibody levels to the receptor-binding domain of SARS-CoV2 spike (S) protein using anti-RBD immunoassay. Anti-S antibody serum levels ≥250 BAU/mL were considered protective. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Efficacy and Safety of mRNA SARS-CoV2 Vaccination in Heart Transplant Recipients
  14. 5154
    por Wang, Chang Yi, Hwang, Kao-Pin, Kuo, Hui-Kai, Peng, Wen-Jiun, Shen, Yea-Huei, Kuo, Be-Sheng, Huang, Juin-Hua, Liu, Hope, Ho, Yu-Hsin, Lin, Feng, Ding, Shuang, Liu, Zhi, Wu, Huan-Ting, Huang, Ching-Tai, Lee, Yuarn-Jang, Liu, Ming-Che, Yang, Yi-Ching, Lu, Po-Liang, Tsai, Hung-Chin, Lee, Chen-Hsiang, Shi, Zhi-Yuan, Liu, Chun-Eng, Liao, Chun-Hsing, Chang, Feng-Yee, Chen, Hsiang-Cheng, Wang, Fu-Der, Hou, Kuo-Liang, Cheng, Jennifer, Wang, Min-Sheng, Yang, Ya-Ting, Chiu, Han-Chen, Jiang, Ming-Han, Shih, Hao-Yu, Shen, Hsuan-Yu, Chang, Po-Yen, Lan, Yu-Rou, Chen, Chi-Tian, Lin, Yi-Ling, Liang, Jian-Jong, Liao, Chun-Che, Chou, Yu-Chi, Morris, Mary Kate, Hanson, Carl V., Guirakhoo, Farshad, Hellerstein, Michael, Yu, Hui-Jing, King, Chwan-Chuen, Kemp, Tracy, Heppner, D. Gray, Monath, Thomas P.
    Publicado 2022
    “…We report phase I/II trial results of UB-612, a multitope subunit vaccine containing S1-RBD-sFc protein and rationally designed promiscuous peptides representing sarbecovirus conserved helper T cell and cytotoxic T lymphocyte epitopes on the nucleocapsid (N), membrane (M), and spike (S2) proteins. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    A multitope SARS-CoV-2 vaccine provides long-lasting B cell and T cell immunity against Delta and Omicron variants
  15. 5155
    “…DESCRIPTION: L’évolution de la réponse humorale (titre d’IgG anti-RBD et capacité de seroneutralisation virale in vitro) et cellulaire (interferon gamma releasing assay, IGRA) a été évaluée chez 62 patients hémodialysés naïfs pour le virus (HD_naïf) entre le pic de la réponse vaccinal et 6 mois après la dernière dose. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Persistance de la réponse vaccinale anti SARS-CoV-2 chez le patient hémodialysé chronique : intérêt d’un rappel à 6 mois
  16. 5156
    “…The anti-SARS-CoV-2 spike (S) protein receptor binding domain (RBD) by chemiluminescence and the neutralizing antibodies by plaque reduction neutralization test (PRNT) were titrated. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Effectiveness, safety, and immunogenicity of half dose ChAdOx1 nCoV-19 COVID-19 Vaccine: Viana project
  17. 5157
    “…Correlation with anti-SARS-CoV-2 binding antibodies was variable, but the strongest correlations were observed between anti-RBD IgG antibodies and Mindray (r = 0.952, R(2) = 0.907). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Evaluation of commercially available fully automated and ELISA-based assays for detecting anti-SARS-CoV-2 neutralizing antibodies
  18. 5158
    “…METHODS: We prospectively measured SARS-COV-2 IgG, memory B-cells specific for SARS-CoV-2 RBD, and memory T-cells secreting IFN-γ and/or IL-2, in MS patients vaccinated with BNT162b2-COVID-19 vaccine before, 1, 3 and 6 months after the second vaccine dose, and 3–6 months following vaccine booster. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    In-depth characterization of long-term humoral and cellular immune responses to COVID-19m-RNA vaccination in multiple sclerosis patients treated with teriflunomide or alemtuzumab
  19. 5159
    “…METHODS: We determined specific anti-RBD (receptor-binding domain) titers against trimeric spike glycoprotein (S) of SARS-CoV-2 by Roche Elecsys Anti-SARS-CoV-2 S immunoassay in serum samples of 35 healthcare workers with a previous documented history of SARS-CoV-2 infection and 158 healthcare workers without, after 1 and 2 doses of vaccine, respectively. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Vaccination strategy and anti - SARS-CoV-2 S titers in healthcare workers of the INT – IRCCS “Fondazione Pascale” Cancer Center (Naples, Italy)
  20. 5160
    “…The primary clinical outcome will be change in pan-lg antibody response (pan-Ig anti-S1-RBD; baseline vs. 3 months after first vaccination; binary outcome, considering ≥ 0.8 units/ml as a positive antibody response). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    A trial platform to assess approved SARS-CoV-2 vaccines in immunocompromised patients: first sub-protocol for a pilot trial comparing the mRNA vaccines Comirnaty® and COVID-19 mRNA Vaccine Moderna®
Herramientas de búsqueda: RSS